Abbie Celniker - Concepedia

Author

Abbie Celniker

United States Department of Veterans Affairs

Also Known As

A C Celniker, A Celniker, A. CELNIKER, A. Celniker, ABBIE C. CELNIKER, ABBIE CELNIKER, Abbie C. Celniker, Abbie Celniker, Aura Celniker, Aura F. Celniker

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

United States Department of Veterans Affairs Amgen (United States)University of Arizona Stanford University University of California, Davis

About

Abbie Celniker is an author at United States Department of Veterans Affairs specializing in medicine, pharmacology, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.6K
2	Health Sciences	4	4	364
3	Allergy	2	2	277
4	Education	1	1	30
5	Biochemistry	1	1	610

Abbie Celniker

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules Binodh DeSilva, Wendell C. Smith, Russell Weiner, Pharmaceutical Research Molecular DockingLigand-binding AssaysPharmacokinetic ModelingBiochemistryPreclinical Drug Evaluation	2003	610
A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. Mark L. Hartman, Peter Clayton, Michael L. Johnson, Journal of Clinical Investigation Metabolic SyndromeBody CompositionGrowth HormoneHuman GrowthMedicine	1993	195
Variability in the Quantitation of Circulating Growth Hormone Using Commercial Immunoassays Abbie Celniker, Anthony B. Chen, ROBERT M. WERT, The Journal of Clinical Endocrinology & Metabolism Body CompositionAutoimmune DiseaseAllergyGrowth HormoneMedicine	1989	162
RELAXIN IN THE PERI-IMPLANTATION PERIOD Dennis R. Stewart, Abbie Celniker, Clinton A. Taylor, The Journal of Clinical Endocrinology & Metabolism	1990	157
Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Raymond B. Nagle, Frederick R. Ahmann, Kathleen McDaniel, PubMed Human Prostate TissuePathologyCancer BiologyHuman Prostatic CarcinomaTumor Biology	1987	152
INDUCTION THERAPY WITH MONOCLONAL ANTIBODIES SPECIFIC FOR CD80 AND CD86 DELAYS THE ONSET OF ACUTE RENAL ALLOGRAFT REJECTION IN NON-HUMAN PRIMATES1 Allan D. Kirk, Douglas K. Tadaki, Abbie Celniker, Transplantation	2001	133
The effects of nebulized recombinant interferon-γ in asthmatic airways Mark Boguniewicz, Richard J. Martin, Dannette Martin, Journal of Allergy and Clinical Immunology AsthmaInflammatory Lung DiseaseAllergyLung InflammationRespiratory Diseases	1995	115
Workshop on Bioanalytical Methods Validation for Macromolecules: Summary Report Krys J. Miller, Ronald R. Bowsher, Abbie Celniker, Pharmaceutical Research	2001	112
ATP Assay: Ability To Distinguish Cytostatic From Cytocidal Anticancer Drug Effects<xref ref-type="fn" rid="FN2">2</xref> Harinder S. Garewal, Frederick R. Ahmann, Ron B. Schifman, JNCI Journal of the National Cancer Institute Bioluminescence AssayCellular PharmacologyTumor BiologyMolecular PharmacologyMetronomic Therapy	1986	90
Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. S. Lieberman, Julie Bukar, S A Chen, The Journal of Clinical Endocrinology & Metabolism Human GrowthPathologyIgf-i LevelsInsulin SignalingIgf-binding Proteins	1992	84

Page 1